Data management in the DNA of new gene therapy plant
from Genetic Engineering & Biotechnology News
Officials at Catalent, a CDMO, recently announced plans for a new gene therapy facility, explaining that the $130 million expansion will add five Phase III through commercial-scale manufacturing suites.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063